LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Racial and Ethnic Disparities in Functional Outcome after Thrombectomy: A Cohort Study of an Integrated Stroke Network.

    Jones, Erica / Kumar, Aditya / Lopez-Rivera, Victor / Sebaugh, Jacob / Kamal, Haris / Sheth, Sunil A / Sharrief, Anjail / Zha, Alicia

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

    2021  Volume 30, Issue 12, Page(s) 106131

    Abstract: Objectives: Previous studies have shown racial disparities in access to treatment and outcomes in ischemic stroke patients. We sought to define racial disparities in functional outcomes among ischemic stroke patients receiving endovascular thrombectomy ( ...

    Abstract Objectives: Previous studies have shown racial disparities in access to treatment and outcomes in ischemic stroke patients. We sought to define racial disparities in functional outcomes among ischemic stroke patients receiving endovascular thrombectomy (EVT).
    Materials and methods: We performed a retrospective review of patients in our institution's prospectively collected stroke patient registry from 08/2015 to 06/2019 at 1 comprehensive and 2 thrombectomy-ready stroke centers. We reviewed patients aged ≥ 18 who received mechanical thrombectomy including only patients with race/ethnicity data belonging to the 3 largest race/ethnic groups: Non-Hispanic White (NHW), Non-Hispanic Black (NHB), and Hispanic (HIS). We compared baseline characteristics and performed multivariable logistic regression to evaluate differences in good functional outcome defined as 90-day modified Rankin score (90 day mRS 0-2) as the primary outcome. Secondary outcomes were discharge disposition, length of stay, and excellent functional outcome (90 day mRS 0-1). Results are given as OR [95% CI].
    Results: Among 666 patients that met inclusion criteria, 45% were NHW, 30% were NHB, and 19% were HIS. NHB and HIS patients were younger than NHW (average age NHB 62; HIS 64; and NHW 70; p < 0.001). Diabetes was more prevalent in NHB (32%, p = 0.02) and HIS (47%, p < 0.001) compared to NHW (23%). There were no significant racial differences in pre-morbid mRS, arrival NIHSS, tPA treatment rates. There was no difference in primary outcome by race comparing NHW to the other racial groups (OR 1.08 [0.68-1.72]) but compared to HIS patients, NHW had a higher likelihood of the secondary outcome of excellent functional outcome (aOR 2.23 [1.01-4.93]) defined as mRS 0-1.
    Conclusions: In this study of over 600 patients treated with EVT, we did not find significant racial disparities in functional outcome except for less excellent functional outcome in HIS compared to NHW. Further study on disparities in post-acute stroke care is needed.
    MeSH term(s) Black or African American/statistics & numerical data ; Aged ; Ethnicity/statistics & numerical data ; Health Status Disparities ; Hispanic or Latino/statistics & numerical data ; Humans ; Ischemic Stroke/ethnology ; Ischemic Stroke/physiopathology ; Ischemic Stroke/surgery ; Middle Aged ; Racial Groups/statistics & numerical data ; Retrospective Studies ; Thrombectomy ; Treatment Outcome ; White People/statistics & numerical data
    Language English
    Publishing date 2021-10-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1131675-5
    ISSN 1532-8511 ; 1052-3057
    ISSN (online) 1532-8511
    ISSN 1052-3057
    DOI 10.1016/j.jstrokecerebrovasdis.2021.106131
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Endovascular thrombectomy time metrics in the era of COVID-19: observations from the Society of Vascular and Interventional Neurology Multicenter Collaboration.

    Czap, Alexandra L / Zha, Alicia M / Sebaugh, Jacob / Hassan, Ameer E / Shulman, Julie G / Abdalkader, Mohamad / Nguyen, Thanh N / Linfante, Italo / Starosciak, Amy Kathryn / Ortega-Gutierrez, Santiago / Farooqui, Mudassir / Quispe-Orozco, Darko / Vora, Nirav A / Rai, Vivek / Nogueira, Raul G / Haussen, Diogo C / Jillella, Dinesh V / Rana, Ameena / Yu, Siyuan /
    Thon, Jesse M / Zaidat, Osama O / Khandelwal, Priyank / Bach, Ivo / Sheth, Sunil A / Jadhav, Ashutosh P / Desai, Shashvat M / Jovin, Tudor G / Liebeskind, David S / Siegler, James E

    Journal of neurointerventional surgery

    2021  Volume 14, Issue 1

    Abstract: Background: Unprecedented workflow shifts during the coronavirus disease 2019 (COVID-19) pandemic have contributed to delays in acute care delivery, but whether it adversely affected endovascular thrombectomy metrics in acute large vessel occlusion (LVO) ...

    Abstract Background: Unprecedented workflow shifts during the coronavirus disease 2019 (COVID-19) pandemic have contributed to delays in acute care delivery, but whether it adversely affected endovascular thrombectomy metrics in acute large vessel occlusion (LVO) is unknown.
    Methods: We performed a retrospective review of observational data from 14 comprehensive stroke centers in nine US states with acute LVO. EVT metrics were compared between March to July 2019 against March to July 2020 (primary analysis), and between state-specific pre-peak and peak COVID-19 months (secondary analysis), with multivariable adjustment.
    Results: Of the 1364 patients included in the primary analysis (51% female, median NIHSS 14 [IQR 7-21], and 74% of whom underwent EVT), there was no difference in the primary outcome of door-to-puncture (DTP) time between the 2019 control period and the COVID-19 period (median 71 vs 67 min, P=0.10). After adjustment for variables associated with faster DTP, and clustering by site, there remained a trend toward shorter DTP during the pandemic (β
    Conclusions: In this multi-center study, there was no delay in EVT among patients treated for intracranial occlusion during the COVID-19 era compared with the pre-COVID era.
    MeSH term(s) Benchmarking ; COVID-19 ; Endovascular Procedures ; Female ; Humans ; Male ; Neurology ; Retrospective Studies ; SARS-CoV-2 ; Stroke/diagnostic imaging ; Stroke/surgery ; Thrombectomy ; Time-to-Treatment ; Treatment Outcome
    Language English
    Publishing date 2021-02-08
    Publishing country England
    Document type Journal Article ; Multicenter Study
    ZDB-ID 2514982-9
    ISSN 1759-8486 ; 1759-8478
    ISSN (online) 1759-8486
    ISSN 1759-8478
    DOI 10.1136/neurintsurg-2020-017205
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic: The Society of Vascular and Interventional Neurology Multicenter Collaboration.

    Ortega-Gutierrez, Santiago / Farooqui, Mudassir / Zha, Alicia / Czap, Alexandra / Sebaugh, Jacob / Desai, Shashvat / Jadhav, Ashutosh / Vora, Nirav / Rai, Vivek / Jovin, Tudor G / Thon, Jesse M / Heslin, Mark / Thau, Lauren / Zevallos, Cynthia / Quispe-Orozco, Darko / Jillella, Dinesh V / Nahab, Fadi / Mohammaden, Mahmoud H / Nogueira, Raul G /
    Haussen, Diogo C / Nguyen, Thanh N / Romero, Jose Rafael / Aparicio, Hugo J / Osman, Mohamed / Haq, Israr Ul / Liebeskind, David / Hassan, Ameer E / Zaidat, Osama / Siegler, James E

    Clinical neurology and neurosurgery

    2020  Volume 201, Page(s) 106436

    Abstract: Background: To evaluate overall ischemic stroke volumes and rates, specific subtypes, and clinical presentation during the COVID-19 pandemic in a multicenter observational study from eight states across US.: Methods: We compared all ischemic strokes ... ...

    Abstract Background: To evaluate overall ischemic stroke volumes and rates, specific subtypes, and clinical presentation during the COVID-19 pandemic in a multicenter observational study from eight states across US.
    Methods: We compared all ischemic strokes admitted between January 2019 and May 2020, grouped as; March-May 2020 (COVID-19 period) and March-May 2019 (seasonal pre-COVID-19 period). Primary outcome was stroke severity at admission measured by NIHSS stratified as mild (0-7), moderate [8-14], and severe (>14). Secondary outcomes were volume of large vessel occlusions (LVOs), stroke etiology, IV-tPA rates, and discharge disposition.
    Results: Of the 7969 patients diagnosed with acute ischemic stroke during the study period, 933 (12 %) presented in the COVID-19 period while 1319 (17 %) presented in the seasonal pre-COVID-19 period. Significant decline was observed in the mean weekly volumes of newly diagnosed ischemic strokes (98 ± 3 vs 50 ± 20,p = 0.003), LVOs (16.5 ± 3.8 vs 8.3 ± 5.9,p = 0.008), and IV-tPA (10.9 ± 3.4 vs 5.3 ± 2.9,p = 0.0047), whereas the mean weekly proportion of LVOs (18 % ±5 vs 16 % ±7,p = 0.24) and IV-tPA (10.4 % ±4.5 vs. 9.9 % ±2.4,p = 0.66) remained the same, when compared to the seasonal pre-COVID-19 period. Additionally, an increased proportion of patients presented with a severe disease (NIHSS > 14) during the COVID-19 period (29.7 % vs 24.5 %,p < 0.025). The odds of being discharged to home were 26 % greater in the COVID-19 period when compared to seasonal pre-COVID-19 period (OR:1.26, 95 % CI:1.07-1.49,p = 0.016).
    Conclusions: During COVID-19 period there was a decrease in volume of newly diagnosed ischemic stroke cases and IV-tPA administration. Patients admitted to the hospital had severe neurological clinical presentation and were more likely to discharge home.
    MeSH term(s) Administration, Intravenous ; Adult ; Aged ; Aged, 80 and over ; COVID-19/diagnosis ; COVID-19/epidemiology ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Neurology/trends ; Pandemics ; Retrospective Studies ; Societies, Medical/trends ; Stroke/diagnosis ; Stroke/drug therapy ; Stroke/epidemiology ; Thrombolytic Therapy/trends ; Tissue Plasminogen Activator/administration & dosage ; United States/epidemiology ; Vascular Diseases/drug therapy ; Vascular Diseases/epidemiology
    Chemical Substances Tissue Plasminogen Activator (EC 3.4.21.68)
    Language English
    Publishing date 2020-12-15
    Publishing country Netherlands
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 193107-6
    ISSN 1872-6968 ; 0303-8467
    ISSN (online) 1872-6968
    ISSN 0303-8467
    DOI 10.1016/j.clineuro.2020.106436
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry.

    Siegler, James E / Cardona, Pere / Arenillas, Juan F / Talavera, Blanca / Guillen, Ana N / Chavarría-Miranda, Alba / de Lera, Mercedes / Khandelwal, Priyank / Bach, Ivo / Patel, Pratit / Singla, Amit / Requena, Manuel / Ribo, Marc / Jillella, Dinesh V / Rangaraju, Srikant / Nogueira, Raul G / Haussen, Diogo C / Vazquez, Alejandro R / Urra, Xabier /
    Chamorro, Ángel / Román, Luis S / Thon, Jesse M / Then, Ryna / Sanborn, Emma / de la Ossa, Natalia P / Millàn, Mònica / Ruiz, Isaac N / Mansour, Ossama Y / Megahed, Mohammed / Tiu, Cristina / Terecoasa, Elena O / Radu, Răzvan A / Nguyen, Thanh N / Curiale, Gioacchino / Kaliaev, Artem / Czap, Alexandra L / Sebaugh, Jacob / Zha, Alicia M / Liebeskind, David S / Ortega-Gutierrez, Santiago / Farooqui, Mudassir / Hassan, Ameer E / Preston, Laurie / Patterson, Mary S / Bushnaq, Saif / Zaidat, Osama / Jovin, Tudor G

    International journal of stroke : official journal of the International Stroke Society

    2020  Volume 16, Issue 4, Page(s) 437–447

    Abstract: Background: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients.: Aim: To summarize the findings of a multinational observational cohort of patients ... ...

    Abstract Background: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients.
    Aim: To summarize the findings of a multinational observational cohort of patients with SARS-CoV-2 and cerebrovascular disease.
    Methods: Retrospective observational cohort of consecutive adults evaluated in the emergency department and/or admitted with coronavirus disease 2019 (COVID-19) across 31 hospitals in four countries (1 February 2020-16 June 2020). The primary outcome was the incidence rate of cerebrovascular events, inclusive of acute ischemic stroke, intracranial hemorrhages (ICH), and cortical vein and/or sinus thrombosis (CVST).
    Results: Of the 14,483 patients with laboratory-confirmed SARS-CoV-2, 172 were diagnosed with an acute cerebrovascular event (1.13% of cohort; 1130/100,000 patients, 95%CI 970-1320/100,000), 68/171 (40.5%) were female and 96/172 (55.8%) were between the ages 60 and 79 years. Of these, 156 had acute ischemic stroke (1.08%; 1080/100,000 95%CI 920-1260/100,000), 28 ICH (0.19%; 190/100,000 95%CI 130-280/100,000), and 3 with CVST (0.02%; 20/100,000, 95%CI 4-60/100,000). The in-hospital mortality rate for SARS-CoV-2-associated stroke was 38.1% and for ICH 58.3%. After adjusting for clustering by site and age, baseline stroke severity, and all predictors of in-hospital mortality found in univariate regression (p < 0.1: male sex, tobacco use, arrival by emergency medical services, lower platelet and lymphocyte counts, and intracranial occlusion), cryptogenic stroke mechanism (aOR 5.01, 95%CI 1.63-15.44, p < 0.01), older age (aOR 1.78, 95%CI 1.07-2.94, p = 0.03), and lower lymphocyte count on admission (aOR 0.58, 95%CI 0.34-0.98, p = 0.04) were the only independent predictors of mortality among patients with stroke and COVID-19.
    Conclusions: COVID-19 is associated with a small but significant risk of clinically relevant cerebrovascular events, particularly ischemic stroke. The mortality rate is high for COVID-19-associated cerebrovascular complications; therefore, aggressive monitoring and early intervention should be pursued to mitigate poor outcomes.
    MeSH term(s) Adult ; Age Factors ; Aged ; Aged, 80 and over ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/therapy ; Cerebrovascular Disorders/epidemiology ; Cerebrovascular Disorders/etiology ; Cerebrovascular Disorders/therapy ; Cohort Studies ; Female ; Hospital Mortality ; Humans ; Intracranial Hemorrhages/epidemiology ; Ischemic Stroke/epidemiology ; Ischemic Stroke/etiology ; Ischemic Stroke/therapy ; Lymphocyte Count ; Male ; Middle Aged ; Prevalence ; Registries ; Retrospective Studies ; Risk Factors ; Sex Factors ; Thrombosis/etiology ; Tobacco Use ; Young Adult
    Keywords covid19
    Language English
    Publishing date 2020-09-30
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 2303728-3
    ISSN 1747-4949 ; 1747-4930
    ISSN (online) 1747-4949
    ISSN 1747-4930
    DOI 10.1177/1747493020959216
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry

    Siegler, James E / Cardona, Pere / Arenillas, Juan F / Talavera, Blanca / Guillen, Ana N / Chavarría-Miranda, Alba / de Lera, Mercedes / Khandelwal, Priyank / Bach, Ivo / Patel, Pratit / Singla, Amit / Requena, Manuel / Ribo, Marc / Jillella, Dinesh V / Rangaraju, Srikant / Nogueira, Raul G / Haussen, Diogo C / Vazquez, Alejandro R / Urra, Xabier /
    Chamorro, Ángel / Román, Luis S / Thon, Jesse M / Then, Ryna / Sanborn, Emma / de la Ossa, Natalia P / Millàn, Mònica / Ruiz, Isaac N / Mansour, Ossama Y / Megahed, Mohammed / Tiu, Cristina / Terecoasa, Elena O / Radu, Razvan A / Nguyen, Thanh N / Curiale, Gioacchino / Kaliaev, Artem / Czap, Alexandra L / Sebaugh, Jacob / Zha, Alicia M / Liebeskind, David S / Ortega-Gutierrez, Santiago / Farooqui, Mudassir / Hassan, Ameer E / Preston, Laurie / Patterson, Mary S / Bushnaq, Saif / Zaidat, Osama / Jovin, Tudor G

    Int J Stroke

    Abstract: BACKGROUND: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients. AIM: To summarize the findings of a multinational observational cohort of patients with ... ...

    Abstract BACKGROUND: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients. AIM: To summarize the findings of a multinational observational cohort of patients with SARS-CoV-2 and cerebrovascular disease. METHODS: Retrospective observational cohort of consecutive adults evaluated in the emergency department and/or admitted with coronavirus disease 2019 (COVID-19) across 31 hospitals in four countries (1 February 2020-16 June 2020). The primary outcome was the incidence rate of cerebrovascular events, inclusive of acute ischemic stroke, intracranial hemorrhages (ICH), and cortical vein and/or sinus thrombosis (CVST). RESULTS: Of the 14,483 patients with laboratory-confirmed SARS-CoV-2, 172 were diagnosed with an acute cerebrovascular event (1.13% of cohort; 1130/100,000 patients, 95%CI 970-1320/100,000), 68/171 (40.5%) were female and 96/172 (55.8%) were between the ages 60 and 79 years. Of these, 156 had acute ischemic stroke (1.08%; 1080/100,000 95%CI 920-1260/100,000), 28 ICH (0.19%; 190/100,000 95%CI 130-280/100,000), and 3 with CVST (0.02%; 20/100,000, 95%CI 4-60/100,000). The in-hospital mortality rate for SARS-CoV-2-associated stroke was 38.1% and for ICH 58.3%. After adjusting for clustering by site and age, baseline stroke severity, and all predictors of in-hospital mortality found in univariate regression (p < 0.1: male sex, tobacco use, arrival by emergency medical services, lower platelet and lymphocyte counts, and intracranial occlusion), cryptogenic stroke mechanism (aOR 5.01, 95%CI 1.63-15.44, p < 0.01), older age (aOR 1.78, 95%CI 1.07-2.94, p = 0.03), and lower lymphocyte count on admission (aOR 0.58, 95%CI 0.34-0.98, p = 0.04) were the only independent predictors of mortality among patients with stroke and COVID-19. CONCLUSIONS: COVID-19 is associated with a small but significant risk of clinically relevant cerebrovascular events, particularly ischemic stroke. The mortality rate is high for COVID-19-associated cerebrovascular complications; therefore, aggressive monitoring and early intervention should be pursued to mitigate poor outcomes.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #806135
    Database COVID19

    Kategorien

  6. Article ; Online: Cerebrovascular events and outcomes in hospitalized patients with COVID-19

    Siegler, James E / Cardona, Pere / Arenillas, Juan F / Talavera, Blanca / Guillen, Ana N / Chavarría-Miranda, Alba / de Lera, Mercedes / Khandelwal, Priyank / Bach, Ivo / Patel, Pratit / Singla, Amit / Requena, Manuel / Ribo, Marc / Jillella, Dinesh V / Rangaraju, Srikant / Nogueira, Raul G / Haussen, Diogo C / Vazquez, Alejandro R / Urra, Xabier /
    Chamorro, Ángel / Román, Luis S / Thon, Jesse M / Then, Ryna / Sanborn, Emma / de la Ossa, Natalia P / Millàn, Mònica / Ruiz, Isaac N / Mansour, Ossama Y / Megahed, Mohammed / Tiu, Cristina / Terecoasa, Elena O / Radu, Răzvan A / Nguyen, Thanh N / Curiale, Gioacchino / Kaliaev, Artem / Czap, Alexandra L / Sebaugh, Jacob / Zha, Alicia M / Liebeskind, David S / Ortega-Gutierrez, Santiago / Farooqui, Mudassir / Hassan, Ameer E / Preston, Laurie / Patterson, Mary S / Bushnaq, Saif / Zaidat, Osama / Jovin, Tudor G

    International Journal of Stroke

    The SVIN COVID-19 Multinational Registry

    2020  , Page(s) 174749302095921

    Abstract: Background Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients. Aim To summarize the findings of a multinational observational cohort of patients with ... ...

    Abstract Background Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients. Aim To summarize the findings of a multinational observational cohort of patients with SARS-CoV-2 and cerebrovascular disease. Methods Retrospective observational cohort of consecutive adults evaluated in the emergency department and/or admitted with coronavirus disease 2019 (COVID-19) across 31 hospitals in four countries (1 February 2020–16 June 2020). The primary outcome was the incidence rate of cerebrovascular events, inclusive of acute ischemic stroke, intracranial hemorrhages (ICH), and cortical vein and/or sinus thrombosis (CVST). Results Of the 14,483 patients with laboratory-confirmed SARS-CoV-2, 172 were diagnosed with an acute cerebrovascular event (1.13% of cohort; 1130/100,000 patients, 95%CI 970–1320/100,000), 68/171 (40.5%) were female and 96/172 (55.8%) were between the ages 60 and 79 years. Of these, 156 had acute ischemic stroke (1.08%; 1080/100,000 95%CI 920–1260/100,000), 28 ICH (0.19%; 190/100,000 95%CI 130–280/100,000), and 3 with CVST (0.02%; 20/100,000, 95%CI 4–60/100,000). The in-hospital mortality rate for SARS-CoV-2-associated stroke was 38.1% and for ICH 58.3%. After adjusting for clustering by site and age, baseline stroke severity, and all predictors of in-hospital mortality found in univariate regression (p < 0.1: male sex, tobacco use, arrival by emergency medical services, lower platelet and lymphocyte counts, and intracranial occlusion), cryptogenic stroke mechanism (aOR 5.01, 95%CI 1.63–15.44, p < 0.01), older age (aOR 1.78, 95%CI 1.07–2.94, p = 0.03), and lower lymphocyte count on admission (aOR 0.58, 95%CI 0.34–0.98, p = 0.04) were the only independent predictors of mortality among patients with stroke and COVID-19. Conclusions COVID-19 is associated with a small but significant risk of clinically relevant cerebrovascular events, particularly ischemic stroke. The mortality rate is high for COVID-19-associated cerebrovascular complications; therefore, aggressive monitoring and early intervention should be pursued to mitigate poor outcomes.
    Keywords Neurology ; covid19
    Language English
    Publisher SAGE Publications
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2303728-3
    ISSN 1747-4930
    ISSN 1747-4930
    DOI 10.1177/1747493020959216
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top